Category Archives: Byetta Cancer

Featured Stories
Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports. According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Study: Type 2 Diabetes Drugs May Lead to Pancreatic Damage

A recent study found that Type 2 diabetics taking drugs such as Januvia and Byetta, might be at increased risk for pancreatic damage, including pancreatic cell growth that could lead to cancer. The study, out of the University of California, … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Some Type 2 Diabetes Drugs Associated with Pancreatitis, Pancreatic Cancer

Some Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

FDA Evaluating Cancer Risks in Type 2 Diabetes Drugs

In a just-released U.S. Food and Drug Administration (FDA) Drug Safety Communication, the agency said it is investigating reports of possible increased risk of pancreatitis and pre-cancerous findings in some Type 2 diabetes drugs. Incretin mimetic drugs imitate the body’s … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

JAMA Study: Januvia, Byetta Double Risks for Pancreatitis

Prior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Januvia, Byetta Linked to Adverse Health Events

Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Researchers at the University of California, Los Angeles looked at the both Januvia and … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amylin Hid Byetta Study Showing Association with Heart Side Effects, FDA Says

Amylin Pharmaceuticals, the maker of Byetta, is coming under fire for allegedly hiding a study that revealed serious heart risks associated with the type 2 diabetes medication.  According to a report from TheStreet.com, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Byetta Cancer, Pharmaceuticals | Tagged |

Pancreas Worries Have Some Docs Backing Away From Byetta, Januvia

A new study indicates that some doctors are becoming wary of Januvia (sitagliptin) and Byetta (exenatide), after research linked the type 2 diabetes drugs to an increased risk of pancreatitis and pancreatic cancer. The survey, conducted by DTW Research, found … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza Raises Thyroid Tumor, Pancreatitis Fears

The maker of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza (liraglutide) is reminding doctors of some serious side effects that may be associated with the Type II Diabetes drug – thyroid C-cell tumors and acute pancreatitis. Novo Nordisk decided to issue a “Dear Healthcare Provider” … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza, Similar Diabetes Drugs Raise Safety Concerns

< "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza, a Type 2 Diabetes drug approved just last year, is raising concerns about pancreatitis. According to the Institute for Safe Medication Practices’ (ISMP) latest “QuarterWatch” report, Victoza has been associated with a growing number of pancreatitis cases since … Continue reading

Posted in Byetta Cancer |

Amylin Wins Temporary Restraining Order in Byetta Spat

Amylin Pharmaceuticals has scored a victory in its quest to prevent Eli Lilly from using its Byetta sales force from marketing a competing drug. < "http://www.yourlawyer.com/topics/overview/Byetta-Side-Effects-Pancreatic-Liver-Thyroid-Cancer-Lawsuit">Byetta, which is treats Type II diabetes, is marketed jointly by Eli Lilly and Amylin. … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.